187 related articles for article (PubMed ID: 22244744)
1. Putative function of TAP63α during endochondral bone formation.
Li F; Lu Y; Ding M; Wu G; Sinha S; Wang S; Zheng Q
Gene; 2012 Mar; 495(2):95-103. PubMed ID: 22244744
[TBL] [Abstract][Full Text] [Related]
2. Distinct function of P63 isoforms during embryonic skeletal development.
Lu Y; Abbassi S; Li F; Ding M; Wu G; Gu J; Zheng Q
Gene; 2013 May; 519(2):251-9. PubMed ID: 23481305
[TBL] [Abstract][Full Text] [Related]
3. Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development.
Ding M; Lu Y; Abbassi S; Li F; Li X; Song Y; Geoffroy V; Im HJ; Zheng Q
J Cell Physiol; 2012 Oct; 227(10):3446-56. PubMed ID: 22223437
[TBL] [Abstract][Full Text] [Related]
4. TAp63γ influences mouse cartilage development.
Wang Q; Li N; Chen F; Hei R; Gu J; Lu Y; Sun L; Zheng Q
Aging (Albany NY); 2020 May; 12(9):8669-8679. PubMed ID: 32392534
[TBL] [Abstract][Full Text] [Related]
5. Mouse p63 variants and chondrogenesis.
Gu J; Lu Y; Qiao L; Ran D; Li N; Cao H; Gao Y; Zheng Q
Int J Clin Exp Pathol; 2013; 6(12):2872-9. PubMed ID: 24294373
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Chondrocyte Survival in Mouse Articular Cartilage by p63.
Taniguchi Y; Kawata M; Ho Chang S; Mori D; Okada K; Kobayashi H; Sugita S; Hosaka Y; Inui H; Taketomi S; Yano F; Ikeda T; Akiyama H; Mills AA; Chung UI; Tanaka S; Kawaguchi H; Saito T
Arthritis Rheumatol; 2017 Mar; 69(3):598-609. PubMed ID: 27792866
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation.
Gu J; Lu Y; Li F; Qiao L; Wang Q; Li N; Borgia JA; Deng Y; Lei G; Zheng Q
Cell Death Dis; 2014 Oct; 5(10):e1469. PubMed ID: 25321476
[TBL] [Abstract][Full Text] [Related]
8. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
[TBL] [Abstract][Full Text] [Related]
9. Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression.
Tavella S; Biticchi R; Schito A; Minina E; Di Martino D; Pagano A; Vortkamp A; Horton WA; Cancedda R; Garofalo S
J Bone Miner Res; 2004 Oct; 19(10):1678-88. PubMed ID: 15355563
[TBL] [Abstract][Full Text] [Related]
10. The p53/p63/p73 family of transcription factors: overlapping and distinct functions.
Levrero M; De Laurenzi V; Costanzo A; Gong J; Wang JY; Melino G
J Cell Sci; 2000 May; 113 ( Pt 10)():1661-70. PubMed ID: 10769197
[TBL] [Abstract][Full Text] [Related]
11. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
12. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
Dohn M; Zhang S; Chen X
Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
[TBL] [Abstract][Full Text] [Related]
13. SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression.
Leung VY; Gao B; Leung KK; Melhado IG; Wynn SL; Au TY; Dung NW; Lau JY; Mak AC; Chan D; Cheah KS
PLoS Genet; 2011 Nov; 7(11):e1002356. PubMed ID: 22072985
[TBL] [Abstract][Full Text] [Related]
14. Functional regulation of p73 and p63: development and cancer.
Melino G; Lu X; Gasco M; Crook T; Knight RA
Trends Biochem Sci; 2003 Dec; 28(12):663-70. PubMed ID: 14659698
[TBL] [Abstract][Full Text] [Related]
15. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
Boominathan L
Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
[TBL] [Abstract][Full Text] [Related]
16. p63 and p73 transcriptionally regulate genes involved in DNA repair.
Lin YL; Sengupta S; Gurdziel K; Bell GW; Jacks T; Flores ER
PLoS Genet; 2009 Oct; 5(10):e1000680. PubMed ID: 19816568
[TBL] [Abstract][Full Text] [Related]
17. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification.
Hattori T; Müller C; Gebhard S; Bauer E; Pausch F; Schlund B; Bösl MR; Hess A; Surmann-Schmitt C; von der Mark H; de Crombrugghe B; von der Mark K
Development; 2010 Mar; 137(6):901-11. PubMed ID: 20179096
[TBL] [Abstract][Full Text] [Related]
18. A highly conserved enhancer in mammalian type X collagen genes drives high levels of tissue-specific expression in hypertrophic cartilage in vitro and in vivo.
Gebhard S; Pöschl E; Riemer S; Bauer E; Hattori T; Eberspaecher H; Zhang Z; Lefebvre V; de Crombrugghe B; von der Mark K
Matrix Biol; 2004 Aug; 23(5):309-22. PubMed ID: 15464363
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 4 deletion results in abnormal chondrocyte hypertrophy and premature ossification from collagen type 2α1‑expressing cells.
Du G; Xiang C; Sang X; Wang X; Shi Y; Wang N; Wang S; Li P; Wei X; Zhang M; Gao L; Zhan H; Wei L
Mol Med Rep; 2020 Nov; 22(5):4031-4040. PubMed ID: 33000215
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
